Managing inflammatory bowel disease (IBD) is becoming increasingly complex and
personalized, considering the advent of new advanced therapies with distinct mechanisms …

Abstract Background and Aims We constructed the Toronto IBD Global Endoscopic
Reporting [TIGER] score for inflammatory bowel disease [IBD]. The aim of our study was to …

Objective: Fecal calprotectin is a noninvasive marker of intestinal inflammation used to
distinguish between functional and organic bowel diseases and to evaluate disease activity …

In inflammatory bowel disease (IBD), mucosal healing is the primary long-term treatment
goal, encompassing both endoscopic and histological outcomes. This paper aims to …

Background and study aims: Endoscopy plays an essential role in managing patients with
ulcerative colitis (UC), as it allows us to visualize and assess the severity of the disease. As …

Abstract Background and Aims: Using sigmoidoscopy as the gold standard, we assessed
the accuracy, and the responsiveness to change, of diffusion-weighted magnetic resonance …

In the past decade, thanks to the introduction of biologic therapies, a new therapeutic goal,
mucosal healing (MH), has been introduced. MH is the expression of an arrest of disease …

Background and study aims Colonoscopies can predict long-term prognoses in patients with
ulcerative colitis (UC). Recently, a new imaging technology has been developed that uses 3 …

Endoscopy is a keystone in the management of patients with inflammatory bowel disease
(IBD). It is the fundamental diagnostic tool for IBD, and can help discern between ulcerative …